Octreotide Acetate Peptide API — Peptides
WHO-GMP Certified Commercial Pack · Product Code: AKP-API-18

Octreotide Acetate Peptide API

Peptide API Overview: Somatostatin-mimetic octapeptide API with high receptor affinity for acromegaly, carcinoid syndrome, and VIPoma parenteral vials. Indicated for Acromegaly, Neuroendocrine tumours. Supplied as lyophilized crystalline powder (Purity ≥ 99.0% HPLC, CAS 79517-01-4) with Certificate of Analysis (HPLC/MS), stability validation, and export technical dossier. Supplied as Lyophilized Peptide API (Purity ≥ 99.0% (HPLC)) within Pharmaceutical Peptide APIs, complying with EP / USP / ICH Q7 Peptide API Monograph with batch HPLC/MS CoA and regulatory documentation for African and global formulators.
Item Code (SKU)AKP-API-18
CAS Registry No.79517-01-4
Catalog ReferenceAKP-API-18 · SN API-18
Therapeutic SectorPharmaceutical Peptide APIs
Dosage FormLyophilized Peptide API
Active IngredientOctreotide Acetate (CAS 79517-01-4)
Strength / PurityPurity ≥ 99.0% (HPLC)
Clinical IndicationAcromegaly, Neuroendocrine tumours
Specification StandardEP / USP / ICH Q7 Peptide API Monograph
Packaging FormatSealed Type I Glass Vial · Nitrogen Headspace (Bulk / Custom Weights)
Shelf Life24–36 Months (Lyophilized at -20°C)
Storage ConditionsStore lyophilized at -20°C (short-term 2–8°C); protect from moisture and light
Minimum Order Quantity50 Vials
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial & Regulatory Export Ready

Related Peptides & Pharmaceutical Peptide APIs